Dividend Declaration

JPMorgan Claverhouse IT PLC
28 October 2024
 

 

 

LONDON STOCK EXCHANGE ANNOUNCEMENT

 

JPMORGAN CLAVERHOUSE INVESTMENT TRUST PLC

(the 'Company')

 

 

Legal Entity Identifier: 549300NFZYYFSCD52W53

Information disclosed in accordance with DTR 6.1.13

 

Third quarterly interim dividend

 

The Directors have declared that a third quarterly interim dividend of 8.25 pence per share for the year ending 31st December 2024 will be paid on 2nd December 2024 to shareholders on the register at the close of business on 1st November 2024. The ex-dividend date will be 31st October 2024.

 

As announced in the Annual Report, the Board has decided to increase the dividend payable in each of the first three quarters to 8.25 pence from the 8.00 pence paid in the previous financial year, subject to any unforeseen factors and the financial position and performance of the Company at the relevant time.

 

 The Company has increased its total annual dividend for 51 consecutive years and the Board's dividend policy remains to seek to increase the dividend each year and, taking a run of years together, to increase dividends at a rate close to, or above, the rate of inflation.

 

The Company offers the option for shareholders to invest their dividend in a Dividend Reinvestment Plan ('DRIP'), which is managed by the Company's registrar. For details on the DRIP, please contact the Company's Registrar, Computershare Investor Services PLC.

 

The key dates relating to this dividend are given below:

 

Ex-dividend date

31st October 2024

Record date

1st November 2024

Last date for DRIP election

11th November 2024

Payment date

2nd December 2024

 

 

 

28th October 2024

For further information:


 



 

Anmol Dhillon

For and on behalf of


JPMorgan Funds Limited - Company Secretary


0800 20 40 20 (or +44 1268 44 44 70)

 


 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100